Defence technology group Chemring (LSE:CHG) rose more than 4% on Wednesday after its Roke subsidiary secured a long-term American contract for miniature radar altimeters, offering a lift to a division that has faced headwinds at home.

Chemring Group shares were among the firmer performers in the FTSE 250 on Wednesday 14 October after the company announced that Roke, its sensors and information technology business, had signed a significant supply agreement with a US prime defence contractor. The deal, worth at least $170 million over its first five years, gives fresh momentum to Roke's strategy of building defence revenues beyond the UK and comes as the group approaches the end of its financial year on 31 October.

Details of the Roke contract

Under the agreement, Roke will supply its Nav-Sync miniature radar altimeter, a compact device that measures altitude above land or sea at low heights. The company describes the product as the smallest and lightest of its kind designed for high-speed and uncrewed aircraft, with an integrated antenna that reduces size and weight. Such systems have become increasingly important as militaries expand their use of drones and other autonomous platforms.

The initial five-year term is expected to be followed by an arrangement that runs until at least 2035. An initial production order worth $16 million covers the first twelve months, with deliveries starting this month. The customer was not named.

Chief executive Michael Ord described the contract as another milestone in Roke's defence revenue strategy, noting that the business is making international progress despite continuing near-term headwinds in its domestic defence market. That comment reflects a theme that has weighed on the group throughout the year: delays in UK Ministry of Defence procurement decisions, which have slowed some contract awards for Roke.

A mixed first half

Those pressures were visible in the half-year results for the six months to 30 April. Group revenue rose 6.5% to £237.3 million, but underlying operating profit fell 7.5% to £24.5 million, with the margin narrowing to 10.3% from 11.9%. The Sensors and Information division, which includes Roke, was weaker, while the Countermeasures and Energetics division, which produces flares, propellants and explosive components, performed sharply amid elevated demand from NATO countries replenishing stockpiles.

Statutory pre-tax profit fell 27% to £18.8 million, reflecting higher one-off costs, including a £6.7 million impairment linked to the closure of Countermeasures operations in Tennessee. Net debt increased to £144.5 million from £93.3 million as Chemring continued to invest heavily in expanding its energetics production capacity to meet demand. The shares fell almost 5% on the day of those results.

Nonetheless, the group reported a record order book of £1.40 billion, up 8% on a year earlier, and said that 91% of its expected revenue for the 2026 financial year had already been delivered or was covered by orders. Management kept its full-year outlook unchanged, and the interim dividend was raised 4% to 2.8p.

Sector backdrop and what comes next

Chemring (LSE:CHG) operates in a sector that has been supported by rising European defence budgets, with governments across NATO committing to higher spending targets and prioritising munitions supply chains. However, the timing of individual programmes, especially in the UK, has created uneven trading for some suppliers. Investors have also been monitoring changes in the shareholder register, with the company publishing a holdings notification on 6 October.

The Roke contract adds a multi-year revenue stream in the important US market and offers some diversification away from domestic procurement timing. Investors are likely to look to the group's year-end trading statement and subsequent full-year results for updates on order intake, energetics capacity expansion and whether the second half delivered the improvement implied by management's guidance.